Clinical trial

Implications for Management of PET Amyloid Classification Technology

NCT02778971

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2016-06-01

PhaseN/A

Study timeline

Study start (actual)2016-06-01Date precision: month

Registry last updated2023-04-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Mild Cognitive Impairmentunresolved

Dementiaunresolved

Alzheimer's Diseaseunresolved

Interventions

[18F]FlutemetamolDRUG

Sponsors & collaborators

University of Utahlead sponsor

Mapped research locations

Salt Lake CityUtah, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02778971 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.